Advisory Services Network, LLC Immunity Bio, Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$1.25 - $5.21 $3,132 - $13,056	2,506 New	2,506 $12,000
Q1 2023 May 17, 2023	SELL	$1.35 - $4.78 $3,240 - $11,472	-2,400 Reduced 75.0%	800 $1,000
Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.77 $13,919 - $21,664	3,200 New	3,200 $16,000
Q2 2022 Aug 02, 2022	SELL	$2.68 - $6.14 $303,641 - $695,655	-113,299 Closed	0 $0
Q1 2022 May 23, 2022	BUY	$5.05 - $7.53 $572,159 - $853,141	113,299 New	113,299 $636,000

204

70M

1.64M

1.31M

Ticker IBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 400,304,000
Market Cap $1.18B
Description
ImmunityBio, Inc., a clinical-stage biotechnology company, develops therapies and vaccines to treat cancers and infectious diseases. It offers immunotherapy and cell therapy platforms, including antibody cytokine fusion proteins, synthetic immunomodulators, vaccine technologies, natural killer cells, and adaptive (T cell) immune systems. The com...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.